Evidence map›Paper›PMID 30233676›Full record

ArticleExperimental and therapeutic medicine2018

Combination of magnetic resonance imaging and targeted contrast agent for the diagnosis of myocardial infarction.

Jiangjun Qin, Shuchang Zhou, Zhiwei Li, Yinan Chen, Qun Qin, Tao Ai

RetractedOpen access · diamondAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jiangjun QinDepartment of Radiology, The Third People's Hospital of Hainan, Sanya, Hainan 571100, P.R. China.
Shuchang ZhouDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Zhiwei LiDepartment of Radiology, The Third People's Hospital of Hainan, Sanya, Hainan 571100, P.R. China.
Yinan ChenDepartment of Ultrasound, Sanya Maternity and Child Health Care Hospital, Sanya, Hainan 572000, P.R. China.
Qun QinDepartment of Radiology, The Third People's Hospital of Hainan, Sanya, Hainan 571100, P.R. China.
Tao AiDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China.
Sanya Central Hospital · CNHuazhong University of Science and Technology · CNSanya City Women and Children Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial infarction is one of the most common human cerebrovascular conditions and frequently leads to ischemic stroke. Evidence has indicated that magnetic resonance imaging (MRI) is a potential method for the diagnosis of patients with cardiovascular injury. However, the efficacy of MRI in diagnosing patients with myocardial infarction requires to be improved. In the present study, a novel nano-size contrast agent, a chitosan/Fe

Indexed as

chitosan/Fe3O4-enclosed albumindiagnosismagnetic resonance imagingmyocardial infarction

Identifiers

PMID30233676
PMCPMC6143907
OpenAlexW2885200584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.